Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

4.1K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.1K
Viral Recombination00:57

Viral Recombination

25.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Viral Structure00:56

Viral Structure

74.6K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.6K
Viral Mutations00:36

Viral Mutations

39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

794
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
794
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV and spinal cord disease.

Handbook of clinical neurology·2018
Same author

Intravenous Thrombolysis for Stroke and Presumed Stroke in Human Immunodeficiency Virus-Infected Adults: A Retrospective, Multicenter US Study.

Stroke·2017
Same author

Clinical pathologic case report: A 70-year-old man with inflammatory cerebral amyloid angiopathy causing headache, cognitive impairment, and aphasia.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2017
Same author

Case 34-2017. A 76-Year-Old Man with Fever, Weight Loss, and Weakness.

The New England journal of medicine·2017
Same author

Opinion and Special Articles: Creation of a diversity and inclusion certificate program for neurology residents.

Neurology·2017
Same author

Infections of the Nervous System.

The American journal of medicine·2017
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K

Viral Meningitis and Encephalitis.

Jennifer L Lyons

    Continuum (Minneapolis, Minn.)
    |October 2, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Viral meningitis and encephalitis infections, excluding herpes and HIV, lack specific treatments but are preventable through vaccination and prophylaxis. Education is key to preventing these serious nervous system illnesses.

    More Related Videos

    Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
    08:36

    Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

    Published on: April 19, 2024

    1.2K
    Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
    09:35

    Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

    Published on: May 19, 2020

    10.9K

    Related Experiment Videos

    Last Updated: Feb 4, 2026

    A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
    04:23

    A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

    Published on: April 28, 2019

    7.2K
    Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
    08:36

    Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

    Published on: April 19, 2024

    1.2K
    Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
    09:35

    Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

    Published on: May 19, 2020

    10.9K

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Virology

    Background:

    • Meningitis and encephalitis are serious infections affecting the central nervous system.
    • Viral causes are common, but specific treatments are often limited to supportive care.
    • Distinguishing between meningitis and encephalitis is crucial due to differing management and outcomes.

    Purpose of the Study:

    • To review viral meningitis and encephalitis, excluding herpes family viruses and HIV.
    • To highlight the importance of prevention strategies for these infections.

    Main Methods:

    • Literature review of viral meningitis and encephalitis.
    • Focus on non-herpes, non-HIV viral etiologies.
    • Analysis of prevention and management strategies.

    Main Results:

    • Many viral central nervous system infections lack specific antiviral treatments.
    • Prevention is achievable through vaccination, vector protection, and postexposure prophylaxis.
    • Despite rarity, these infections carry significant morbidity and mortality.

    Conclusions:

    • Distinguishing viral meningitis from encephalitis is critical for appropriate patient management.
    • Preventable viral infections of the nervous system underscore the importance of public health measures.
    • Provider and patient education are paramount in preventing severe outcomes from these infections.